News 04 Apr 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
News 27 Ott 2023 UZH researchers develop method for transport of large genes Researchers at the University of Zurich (UZH) have developed a new method for transporting large genes, enabling them to be transferred efficient...
News 20 Ott 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News 08 Mag 2023 RetinAI partners with Boehringer Ingelheim to improve retinal disease treatment Bern-based RetinAI Medical, a pioneer in clinical and imaging data management software and advanced analytics using AI for ophthalmology, has joi...
News 18 Ott 2022 KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based start-up develops products to alleviate neurological disease...
News 26 Ott 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
News 25 Apr 2022 New Metrohm analysis method to assess the quality of food Metrohm has successfully further developed the Rancimat method. This is used to determine the rancidity of edible oils and fats in foodstuffs wit...
News 31 Mag 2022 RetinAI enters a multi-year software license agreement with Novartis Building on their existing relationship, Bern-based RetinAI and pharma giant Novartis have entered a long-term collaboration with a multi-year so...
News 12 Gen 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
News 06 Dic 2021 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News 01 Dic 2021 Sun Genomics sets up European subsidiary in Fribourg Probiotics specialist Sun Genomics has chosen Fribourg to set up its European subsidiary. This is the first establishment of a US company in West...
Third Party Event Philippines and Switzerland: Investing Together for a Better Future Bern Switzerland
News 13 Ott 2021 Valais biotech Novochizol wins an international competition Novochizol, a biotech company with a unique chitosan-based drug formulation nanotechnology, has been selected by Boehringer Ingelheim as one of t...
Fact Sheet 08 Ott 2021 Dietary and Health Supplements in Indonesia Indonesia is an attractive country for the dietary and health supplement market, both for domestic and imported products, due to its large popula...
S-GE Event Tomorrow's Health: Meet the Experts on Diagnostics and AI 17 Giu 2021 17 Giu 2021 Svizzera
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain 17 Giu 2021 17 Giu 2021 Svizzera
Analysis 22 Mar 2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...